𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766

✍ Scribed by Guorong Xu; Gerald Salen; Sarah Shefer; Gene C. Ness; Thomas S. Chen; Zhihong Zhao; Louis Salen; G.Stephen Tint


Book ID
118882000
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
750 KB
Volume
109
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Smith-Lemli-Opitz syndrome produced in r
✍ Chambers, Christopher M.; McLean, Mark P.; Ness, Gene C. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 299 KB πŸ‘ 2 views

A limitation to treating Smith-Lemli-Opitz infants by giving dietary cholesterol is their impaired ability to absorb cholesterol due to a deficiency of bile acids. Since intravenously administered lipoprotein cholesterol should not require bile acids for uptake into tissues, we tested the effects of

Screening for abnormal cholesterol biosy
✍ Honda, Akira; Batta, Ashok K.; Salen, Gerald; Tint, G. Stephen; Chen, Thomas S.; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 2 views

The Smith-Lemli-Opitz syndrome (SLOS) is a common condition caused by deficiency of 7-dehydrocholesterol ⌬ 7 -reductase. The syndrome can usually be diagnosed by demonstrating markedly increased plasma concentrations of the cholesterol precursor, 7-dehydrocholesterol. We describe a simple and rapid